Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
BioFlorida ConferenceBioFlorida Conference
Not Confirmed
Not Confirmed
18-20 November, 2024
Not Confirmed
Not Confirmed
19-21 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
BioFlorida ConferenceBioFlorida Conference
Industry Trade Show
Not Confirmed
18-20 November, 2024
Industry Trade Show
Not Confirmed
19-21 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/chinese-fda-registered-generic-facilities-gain-steam-india-maintains-lead-with-396-facilities
17 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ascentage-pharma-announces-a-new-drug-application-for-its-novel-bcl-2-inhibitor-lisaftoclax-accepted-and-recommended-priority-review-designation-by-cde-of-china-nmpa-302307744.html
06 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ash-2024--results-from-three-clinical-studies-of-ascentage-pharmas-bcl-2-inhibitor-lisaftoclax-selected-for-presentations-including-an-oral-report-302297323.html
06 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ash-2024--studies-of-olverembatinib-selected-for-presentations-including-an-oral-report-for-the-seventh-consecutive-year-302297311.html
13 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/live-from-esmo-2024--ascentage-pharma-releases-latest-data-showing-sustained-clinical-efficacy-of-olverembatinib-in-sdh-deficient-gist-during-a-mini-oral-presentation-302248193.html
08 Sep 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/esmo-2024--ascentage-pharma-to-present-updated-data-of-olverembatinib-in-patients-with-sdh-deficient-gist-during-a-mini-oral-presentation-at-the-2024-esmo-congress-302241379.html
22 Aug 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ascentage-pharma-announces-2024-interim-results-302228775.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?